Company: OSRH
Filing Date: 2025-06-23
Form Type: 424B3
Source: 0001213900-25-056351
Chunk: 31

Company: OSR Holdings, Inc.
Filing Date: 2025-06-23
Form: 424B3
Chunk 31
---
 of shares of our common stock. Depending on market liquidity at the time, sales of shares of our common stock may cause the trading
price of shares of our common stock to decrease. We generally have the right to control the timing and amount of any future sales of
shares of our common stock to White Lion. Additional sales of shares of our common stock, if any, to White Lion will depend upon market
conditions and other factors to be determined by us. We may ultimately decide to sell to White Lion all, some or none of the additional
shares of our common stock that may be available for us to sell pursuant to the ELOC Agreement. If and when we do sell shares of our
common stock to White Lion, after White Lion has acquired shares of our common stock, White Lion may resell all, some or none of such
shares of our common stock at any time or from time to time in its discretion and at different prices. Therefore, sales to White Lion
by us could result in substantial dilution to the interests of other holders of shares of our common stock. In addition, if we sell a
substantial number of shares of our common stock to White Lion under the Issuance Agreements, or if investors expect that we will do
so, the shares held by White Lion will represent a significant portion of our public float and may result in substantial decreases to
the price of our common stock. The actual sales of shares of our common stock or the mere existence of our arrangement with White Lion
may also make it more difficult for us to sell equity or equity-related securities in the future at a time and at a price that we might
otherwise wish to effect such sales.

<div align='center'>18</div>

The market price of shares of our common stock
could drop significantly if White Lion sells shares of common stock or is perceived by the market as intending to sell them. These factors
could also make it more difficult for us to raise additional funds through future offerings of shares of our common stock or other securities.

We may use proceeds from sales of our common stock made pursuant to the ELOC Agreement, Warrant Agreement, and Note Purchase Agreement in ways with which you may not agree or in ways which may not yield a significant return.

We will have broad discretion over the use of
proceeds from sales of our common stock made pursuant to the Issuance Agreements, including for any of the purposes described in the
section entitled “Use of Proceeds,” and you will not have